Archive | SIRION Biotech GmbH

Page 1 of 6
Supporting Lentiviral Vector Development
Supporting Lentiviral Vector Development Learn More >
Supporting Gene Therapy Development with Safer, More Efficacious AAV Vectors
Supporting Gene Therapy Development with Safer, More Efficacious AAV Vectors Learn More >
SIRION Biotech to present Viral Vector Know-How Hub to support Cell & Gene Therapy R&D at ESGCT 2022
SIRION Biotech to present Viral Vector Know-How Hub to support Cell & Gene Therapy R&D at ESGCT 2022 Learn More >
SIRION Biotech to present insights on single cell level gene delivery to ASGCT 25th Anniversary Meeting
SIRION Biotech to present insights on single cell level gene delivery to ASGCT 25th Anniversary Meeting Learn More >
SIRION Biotech achieves ISO-9001:2015 Certification
SIRION Biotech achieves ISO-9001:2015 Certification Learn More >
SIRION teams with Centre for Genomic Regulation to develop NextGen AAV vectors for diabetes gene therapies
SIRION teams with Centre for Genomic Regulation to develop NextGen AAV vectors for diabetes gene therapies Learn More >
51138SIRION recombinant adenoviruses for transient gene expression
SIRION recombinant adenoviruses for transient gene expression Learn More >
50816Succeed with Sirion – Transduction Enhancer LentiBOOST®
Succeed with Sirion – Transduction Enhancer LentiBOOST® Learn More >
50730Succeed with Sirion – Vaccine Strategy
Succeed with Sirion – Vaccine Strategy Learn More >
50652Succeed with Sirion – Transduction Enhancer
Succeed with Sirion – Transduction Enhancer Learn More >
50549Succeed with Sirion – clinically proven poloxamer, LentiBOOST®
Succeed with Sirion – clinically proven poloxamer, LentiBOOST® Learn More >
50487Succeed with Sirion – LentiBOOST® technology
Succeed with Sirion – LentiBOOST® technology Learn More >
Page 1 of 6